Company news
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A (SZSE:000999) news
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Apr 25, 2026: China Resources Sanjiu Medical & Pharmaceutical…
View China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A →
Press releases & updates
China Resources Sanjiu Medical & Pharmaceutical Co: Revenue up 18.62% but net profit down 15.29% as costs and investments surged
April 24, 2026
China Resources Sanjiu Medical & Pharmaceutical Q1 Net Profit Down 15.3% Y/Y
April 24, 2026
China Resources Sanjiu Medical & Pharmaceutical Co: 2025 revenue up 14.43%, net profit up 1.58%, with robust R&D and major acquisition
March 20, 2026
China Resources Sanjiu Medical & Pharma's 2025 Net Profit Up 1.6% Y/Y
March 20, 2026
China Resources Sanjiu Medical & Pharmaceutical Prelim 2025 Net Profit Up 1.6%
February 6, 2026
China Resources Sanjiu Medical & Pharmaceutical Co: Revenue surged but profit declined as acquisition and investment costs rose sharply
October 25, 2025
China Resources Sanjiu Medical & Pharmaceutical Q3 Net Profit Down 4.3% Y/Y
October 24, 2025
China Resources Sanjiu Medical & Pharma To Invest In Wealth Management Products
September 17, 2025
China Resources Sanjiu Medical & Pharmaceutical Co: Revenue up 4.99% but net profit down 24.31% as Tasly acquisition reshapes business
August 16, 2025
China Resources Sanjiu Medical & Pharmaceutical Co: Revenue and profit declined, but asset growth and Tasly integration drive future potential
April 29, 2025
China Resources Sanjiu Medical & Pharmaceutical Co: Revenue and net profit surged on strong CHC and prescription drug growth, with a 50% payout
March 13, 2025
China Resources Sanjiu Medical & Pharmaceutical Co: Net profit jumped 23.19% year-over-year, with strategic M&A and innovation fueling growth
October 25, 2024
China Resources Sanjiu Medical & Pharmaceutical Co: H1 2024 net profit rose 27.8% on 7.3% revenue growth, driven by CHC business strength
August 30, 2024